Abiopharma

Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion

World-Renowned Alzheimers Expert Prof. Steven Arnold Joins NeuroSense SAB

Biofrontera Notification (BFRI)

VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats

Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones

(10% Negative) Xilio Therapeutics, Inc. (XLO) Announces Delay in million Trials for gross proceeds from Series B warrant exercises Due to Geopolitical Situation, Regulatory Process, Safety Review, Efficacy Assessment

(99% Neutral) ARDELYX, INC. (ARDX) Reports Q1 2026 Financial Results

Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines

(99% Neutral) SELLAS Life Sciences Group, Inc. (SLS) Reports Q1 2026 Financial Results

(99% Neutral) Alaunos Therapeutics, Inc. (TCRT) Announces Clinical Development Update

RenovoRx To Announce Promising New Clinical Data Using itsTAMP™ Therapy Platform in an Abstract to be Presented at ASCO GI 2026

NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp

Veeva and BioMarin Form Long-Term Strategic Partnership

ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004

Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates